Viewing by:
Existing and emerging biotech advances are transforming the way we preserve and transport donated organs. While their methods may vary, all share a common end
“Is it possible to achieve successful VCA transplantation after 72hrs ischemia at sub-zero temperature?” @X-Therma is pleased to get the answer revealed during the highly
We are honored to be featured in the May Issue of AIChE – American Institute of Chemical Engineers. Special thank you to the National Science
X-Therma Inc. received 1st place in the fierce top 15 competition to win the 2018 annual SVIEF Star Award.
X-Therma Inc. received 2nd place for the 2018 International Marine Innovation and Entrepreneurship Competition in Qingdao, China for XT-ViVo, the ocean-inspired nanoscience breakthrough to revolutionize the cold
X-Therma is competitively selected for a third US Department of the Army SBIR Phase II SBIR contract. X-Therma’s CryomatrixTM is a new pipeline of non-toxic
X-Therma is competitively selected for a second US Department of Defense Phase II SBIR contract. This contract funds genitourinary organ transplants performed with XT-ViVoTM cryopreserved
X-Therma is featured in “Wirtschaftswoche“ – top weekly magazine in German Economy. —59 Valley Talk: Investoren begeistern sich für Transplantationstechnik, WirtschaftsWoche Ausgabe 42/2016
X-Therma is competitively selected by for a US Department of Defense Phase II SBIR contract. Murine heart transplants will be performed with XT-ViVoTM cryo
"*" indicates required fields
X-Therma, Inc.
2600 Hilltop Drive
Suite B220
Richmond, CA 94806
USA
Kaiserjägerstraße 30
6020 Innsbruck
Austria
2600 Hilltop Drive
Suite B220
Richmond, CA 94806
USA
Kaiserjägerstraße 30
6020 Innsbruck
Austria
